Skip to main content
Tech.euFundingExplorerBeta

Merus

Exited

Antibody engineering to battle cancer

Utrecht, NetherlandsFounded 2003www.merus.nl
Total raised
€126M
€125,500,000
Funding rounds
3
Investors
5
distinct backers
Active since
2006-12
latest 2015-07

Funding by year

EUR raised per year

Exit

Type
acquisition
Date
Sep 2025
Value
€6.8B
Acquiror
Genmab (Denmark)

Related news

Similar companies

same sector or country